FI945777A0 - Isopropyyli(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro-2,6-dimetyylipyridiini-3,5-dikarboksylaatti - Google Patents

Isopropyyli(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro-2,6-dimetyylipyridiini-3,5-dikarboksylaatti

Info

Publication number
FI945777A0
FI945777A0 FI945777A FI945777A FI945777A0 FI 945777 A0 FI945777 A0 FI 945777A0 FI 945777 A FI945777 A FI 945777A FI 945777 A FI945777 A FI 945777A FI 945777 A0 FI945777 A0 FI 945777A0
Authority
FI
Finland
Prior art keywords
dimethylpyridine
cyanophenyl
methoxyethyl
dihydro
chloro
Prior art date
Application number
FI945777A
Other languages
English (en)
Swedish (sv)
Other versions
FI945777A (fi
FI105681B (fi
Inventor
Heinrich Meier
Wolfgang Hartwig
Bodo Junge
Rudolf Schohe-Loop
Zhan Gao
Bernard Schmidt
Jonge Maarten De
Teunis Schuurman
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4342194A external-priority patent/DE4342194A1/de
Priority claimed from DE19944424677 external-priority patent/DE4424677A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI945777A0 publication Critical patent/FI945777A0/fi
Publication of FI945777A publication Critical patent/FI945777A/fi
Application granted granted Critical
Publication of FI105681B publication Critical patent/FI105681B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
FI945777A 1993-12-10 1994-12-08 Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote FI105681B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4342194A DE4342194A1 (de) 1993-12-10 1993-12-10 Halogen-phenyl-substituierte 1,4-Dihydropyridine
DE4342194 1993-12-10
DE4424677 1994-07-13
DE19944424677 DE4424677A1 (de) 1994-07-13 1994-07-13 Isopropyl-(2-methoxyethyl)-4-(2-chlor-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylat

Publications (3)

Publication Number Publication Date
FI945777A0 true FI945777A0 (fi) 1994-12-08
FI945777A FI945777A (fi) 1995-06-11
FI105681B FI105681B (fi) 2000-09-29

Family

ID=25931956

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945777A FI105681B (fi) 1993-12-10 1994-12-08 Menetelmä terapeuttisesti käyttökelpoisen isopropyyli-(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro- 2,6-dimetyylipyridiini-3,5-dikarboksylaatin valmistamiseksi sekä menetelmän välituote

Country Status (35)

Country Link
US (1) US5665740A (fi)
EP (1) EP0657430B1 (fi)
JP (1) JP3751041B2 (fi)
KR (1) KR100332325B1 (fi)
CN (2) CN1056606C (fi)
AT (1) ATE180774T1 (fi)
AU (1) AU686976B2 (fi)
BG (1) BG62487B1 (fi)
CA (1) CA2137525C (fi)
CO (1) CO4290426A1 (fi)
CU (1) CU22713A3 (fi)
CZ (1) CZ286065B6 (fi)
DE (1) DE59408350D1 (fi)
DK (1) DK0657430T3 (fi)
DZ (1) DZ1831A1 (fi)
EE (1) EE03192B1 (fi)
ES (1) ES2132308T3 (fi)
FI (1) FI105681B (fi)
GR (1) GR3030436T3 (fi)
HR (1) HRP940967B1 (fi)
HU (1) HU215593B (fi)
IL (1) IL111922A (fi)
LV (1) LV11321B (fi)
MA (1) MA23392A1 (fi)
MY (1) MY111976A (fi)
NO (1) NO302362B1 (fi)
NZ (1) NZ270087A (fi)
PL (1) PL179973B1 (fi)
RO (1) RO115800B1 (fi)
SA (1) SA95160078B1 (fi)
SK (1) SK282399B6 (fi)
SV (1) SV1994000072A (fi)
TN (1) TNSN94127A1 (fi)
TW (1) TW412529B (fi)
YU (1) YU48920B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080026081A1 (en) * 2003-11-21 2008-01-31 Axel Unterbeck Methods of Treatment Using (+)-Isopropyl 2-Ethoxyethyl-4-(2-Chloro-3-Cyano-Phenyl)-1,4-Dihydro-2,6-Dimethyl-Pyridine-3,5-Dicarboxylate
WO2008058234A2 (en) * 2006-11-08 2008-05-15 Memory Pharmaceuticals Corporation Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility
WO2019104041A1 (en) * 2017-11-21 2019-05-31 Michael Ohlmeyer Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
US3932646A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylate
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3239273A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
DE3718398A1 (de) * 1987-06-02 1988-12-22 Troponwerke Gmbh & Co Kg Neue kombinationspraeparate mit antidepressiver wirkung
US5114946A (en) * 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
DE3806277A1 (de) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg Verwendung von 1,4-dihydropyridin-derivaten
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Also Published As

Publication number Publication date
HU215593B (hu) 1999-01-28
YU71794A (sh) 1996-10-18
JPH07242632A (ja) 1995-09-19
LV11321A (lv) 1996-06-20
NO302362B1 (no) 1998-02-23
SK282399B6 (sk) 2002-01-07
KR950017958A (ko) 1995-07-22
IL111922A (en) 1999-05-09
EE03192B1 (et) 1999-06-15
BG99249A (en) 1995-09-29
EP0657430B1 (de) 1999-06-02
NO944787L (no) 1995-06-12
JP3751041B2 (ja) 2006-03-01
PL306157A1 (en) 1995-06-12
LV11321B (en) 1996-12-20
CA2137525C (en) 2005-07-12
HRP940967B1 (en) 1999-12-31
CN1109874A (zh) 1995-10-11
DE59408350D1 (de) 1999-07-08
HRP940967A2 (en) 1997-08-31
KR100332325B1 (ko) 2002-09-04
DK0657430T3 (da) 1999-11-15
MA23392A1 (fr) 1995-07-01
CO4290426A1 (es) 1996-04-17
DZ1831A1 (fr) 2002-02-17
AU8030694A (en) 1995-06-15
ES2132308T3 (es) 1999-08-16
CN1124258C (zh) 2003-10-15
CA2137525A1 (en) 1995-06-11
RO115800B1 (ro) 2000-06-30
BG62487B1 (bg) 1999-12-30
NO944787D0 (no) 1994-12-09
NZ270087A (en) 1996-08-27
TW412529B (en) 2000-11-21
ATE180774T1 (de) 1999-06-15
GR3030436T3 (en) 1999-09-30
AU686976B2 (en) 1998-02-12
YU48920B (sh) 2002-11-15
EP0657430A1 (de) 1995-06-14
CZ286065B6 (cs) 2000-01-12
CN1244525A (zh) 2000-02-16
SK151694A3 (en) 1995-07-11
PL179973B1 (pl) 2000-11-30
TNSN94127A1 (en) 1995-09-21
US5665740A (en) 1997-09-09
HU9403551D0 (en) 1995-02-28
FI945777A (fi) 1995-06-11
CZ309394A3 (en) 1995-11-15
CU22713A3 (es) 1996-07-05
HUT70937A (en) 1995-11-28
IL111922A0 (en) 1995-03-15
MY111976A (en) 2001-03-31
SA95160078B1 (ar) 2006-09-25
CN1056606C (zh) 2000-09-20
SV1994000072A (es) 1995-08-09
FI105681B (fi) 2000-09-29

Similar Documents

Publication Publication Date Title
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
FR2691065B1 (fr) Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.
EE04551B1 (et) Optiliselt aktiivne pridl-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
FI945777A0 (fi) Isopropyyli(2-metoksietyyli)-4-(2-kloori-3-syaanifenyyli)-1,4-dihydro-2,6-dimetyylipyridiini-3,5-dikarboksylaatti
NO970573L (no) Ylidenforbindelser og deres fremstilling
DK671187A (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner ved behandling af neurodegenerative sygdomme
DK0523013T3 (da) Anvendelse af benzimidazolin-2-oxo-1-carboxylsyrederivater ved behandling af organiske mentale sygdomme
NO993126D0 (no) Anvendelse av benzoylalkyl-1,2,3,6-tetrahydropyridiner
SE9203857D0 (sv) Use of an enantiomeric dihydropyridine
ZA971323B (en) Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin 1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

MM Patent lapsed